Role of interventional radiology in managing pediatric liver tumors

Hepatoblastoma and hepatocellular carcinoma (HCC) are the most common pediatric liver malignancies, with hepatoblastoma occurring more commonly in younger children and HCC occurring more commonly in older children and adolescents. Although surgical resection (including transplant when necessary) and...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric radiology 2018-04, Vol.48 (4), p.565-580
Main Authors: Hawkins, C Matthew, Towbin, Alexander J, Roebuck, Derek J, Monroe, Eric J, Gill, Anne E, Thakor, Avnesh S, Towbin, Richard B, Cahill, Anne Marie, Lungren, Matthew P
Format: Article
Language:English
Subjects:
Adolescents
Biopsy
Cardiovascular system
Chemotherapy
Children
Cytotoxicity
Diagnosis
Embolization
Hepatocellular carcinoma
Hypertrophy
Liver
Liver cancer
Medical prognosis
Pediatrics
Portal vein
Radiology
Survival
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatoblastoma and hepatocellular carcinoma (HCC) are the most common pediatric liver malignancies, with hepatoblastoma occurring more commonly in younger children and HCC occurring more commonly in older children and adolescents. Although surgical resection (including transplant when necessary) and systemic chemotherapy have improved overall survival rate for hepatoblastoma to approximately 80% from 30%, a number of children with this tumor type are not eligible for operative treatment. In contradistinction, pediatric HCC continues to carry a dismal prognosis with an overall 5-year survival rate of 30%. The Paediatric Hepatic International Tumour Trial (PHITT) is an international trial aimed at evaluating both existing and emerging oncologic therapies for primary pediatric liver tumors. Interventional radiology offers a number of minimally invasive procedures that aid in diagnosis and therapy of pediatric liver tumors. For diagnosis, the PHITT biopsy guidelines emphasize and recommend percutaneous image-guided tumor biopsy. Additionally, both percutaneous and endovascular procedures provide therapeutic alternatives that have been, to this point, only minimally utilized in the pediatric population. Specifically, percutaneous ablation offers a number of cytotoxic technologies that can potentially eradicate disease or downstage children with unresectable disease. Percutaneous portal vein embolization is an additional minimally invasive procedure that might be useful to induce remnant liver hypertrophy prior to extended liver resection in the setting of a primary liver tumor. PHITT offers an opportunity to collect data from children treated with these emerging therapeutic options across the world. The purpose of this manuscript is to describe the potential role of minimally invasive percutaneous transhepatic procedures, as well as review the existing data largely stemming from the adult HCC experience.
ISSN:0301-0449
1432-1998
DOI:10.1007/s00247-018-4072-5